Biotech, Health Tech, and Senior Well-being
Key Questions
What progress has been made in pancreatic cancer treatments?
ASCO 2026 highlighted a historic breakthrough with a pill-based treatment, while Daraxonrasib doubled survival in the RASolute-302 trial. Additional advances include KRAS drugs, mRNA vaccines, and AI detection methods.
How is new imaging technology improving cancer diagnosis?
A stain-free system using silicon slides reduces tissue preparation time by 40-50% while maintaining 99% agreement with traditional methods. It also supports faster AI-assisted analysis.
What funding has Isomorphic Labs raised?
Isomorphic Labs secured a $2.1B Series B round to advance its AI-driven drug discovery efforts. This builds on broader biotech investments including Century Health's $5M seed.
What research is Anima Anandkumar advancing in ultrasound?
Anima Anandkumar's work explores end-to-end ultrasound using neural operators for lung aeration assessment. This aims to improve efficiency in medical imaging applications.
What potential does the MOTS-c peptide show?
MOTS-c demonstrates promise for treating diabetes and improving metabolic health. Ongoing studies explore its role in broader therapeutic applications.
AI-designed universal coronavirus vaccine enters human trials (Cambridge). Longevity podcast: Retro Biosciences ($1.8B) frames aging as treatable disease. Ovarian cancer treatment Elahere approved. YC startup builds MRI in 101 days. Gene editing cholesterol breakthroughs. Isomorphic Labs $2.1B Series B. Century Health $5M seed. Semble £30M. $5 stethoscope. China space station samples. Dimension Capital $750M fund. Pancreatic cancer breakthroughs: Daraxonrasib doubles survival in RASolute-302 trial; KRAS drugs, mRNA vaccines, AI detection. Dana-Farber shows promise with another pancreatic cancer drug. BioVie's bezisterim shows promise in neurodegenerative diseases (Parkinson's, Alzheimer's, Long COVID) with Phase 2 readouts due Q3 2026. Reid Hoffman leaves Microsoft board to focus on Manas AI, an AI-native biopharma venture. Collate raises $95M Series A for AI in regulated life sciences workflows. Google DeepMind and Sanger Institute partner on AI-ready genomic datasets ($5M/year). Stepful raises $55M for AI healthcare workforce training. Gene editing sickle cell breakthrough shows promise in adolescents. AI in physical therapy podcast offers practical insights. Podcast with Nobel laureate Doudna explores CRISPR future. Pancreatic cancer innovations highlighted: KRAS inhibitors, neoantigen vaccines, AI detection. Novavax Matrix-M adjuvant and protein-based vaccine tech under HHS regulatory uncertainty. CRISPR-Cas9 breakthrough for ATTR-CM (transthyretin amyloidosis cardiomyopathy). New: Radical Numerics launches with $50M seed for AI-powered biological intelligence. General-purpose LLMs outperform specialized clinical AI tools, challenging domain-specific assumptions. Cancer genomics: Severus algorithm detects missed structural variants in pediatric leukemia. AI cancer detection (TransUNet) by Jieneng Chen shows promise. ASCO 2026 highlights historic pancreatic cancer breakthrough with pill-based treatment. AI improves challenging reaction in medicinal chemistry. MOTS-c peptide shows promise for diabetes and metabolic health. Latest: New imaging technology speeds cancer diagnosis (stain-free, 40-50% faster prep, 99% agreement). Novavax Matrix-M adjuvant Q&A highlights regulatory uncertainty. Anima Anandkumar's neural operator for ultrasound lung aeration.